Drug
Balovaptan clinical trials
Also written RO5285119.
- studies test it
- 14
- open now
- 0
- in phase 3
- 1
- first study started
- 2011
How studies write it
Studies that test it under each name
Name
Studies by the year they started
14 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2022 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Often tested with
Tested in the same studies.
Itraconazole (2) · Esomeprazole (1) · Risperidone (1) · Fluoxetine (1)
Studies
Open first, then newest update. How each study uses balovaptan is read from its arms, and is right about nine times in ten.
Testing it · 14
- Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)CompletedPhase 2Hoffmann-La RocheNCT05401565Written as Balovaptan
- Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain EdemaWithdrawnPhase 2Hoffmann-La RocheNCT05399550Written as Balovaptan
- The Effect of Hepatic Impairment on the Pharmacokinetics of BalovaptanWithdrawnPhase 1Hoffmann-La RocheNCT03912350Written as Balovaptan
- A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label ExtensionTerminatedPhase 3Hoffmann-La RocheNCT03504917Written as Balovaptan
- A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT04156646Written as Balovaptan
- A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)TerminatedPhase 2Hoffmann-La RocheNCT02901431Written as RO5285119
- A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum DisorderTerminatedPhase 1Hoffmann-La RocheNCT04049578Written as Balovaptan
- A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT03764449Written as Oral Balovaptan
- A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT03579719Written as Balovaptan
- A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)CompletedPhase 2Hoffmann-La RocheNCT01793441Written as RG7314
- A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male VolunteersCompletedPhase 1Hoffmann-La RocheNCT02179866Written as RO5285119
- A Study of RO5285119 in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01418963Written as RO5285119
- A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01708616Written as RO5285119
- A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy SubjectsCompletedPhase 1Hoffmann-La RocheNCT01967979Written as RO5285119
Given in every arm · 1 — balovaptan is usual care beside what is tested
Codes
What other systems call balovaptan · ClinicalTrials.gg INT001365
- MeSH (NLM) C000708839balovaptanConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) RAX5D5AGV6BALOVAPTANConfirmed FDA, NLM, Wikidata
- Wikidata Q56653682balovaptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169802BalovaptanOne source FDA
- DrugBank DB14823One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000708839 | balovaptan | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | RAX5D5AGV6 | BALOVAPTAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q56653682 | balovaptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169802 | Balovaptan | One source FDA |
| DrugBank | DB14823 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.